Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Stein J, Minkin R, Parikh MA, et. al. "Understanding Nicotine Addiction: Personalizing Therapy for Smoking Cessation." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001221
- Whitford T, Goldberg C, Frishman WH, et. al. "Touch, Trust, and Truth; Why the Physical Exam Still Matters In the Age of AI: A Framework for the Physical Exam as a Bridge to Trust, Healing, and Increased Patient Adherence." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001214
- Thukral J, Kaur H, Sindhwani N, et. al. "VEGF Inhibitors in Hematologic Cancers and Hypertension/Cardiac Effects." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001219
- Jha M, Chahodiya D, Thaker L, et. al. "Oral Anticoagulation Versus No Anticoagulation in Patients of Atrial Fibrillation With Prior History of Intracranial Hemorrhage: A Meta-Analysis." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001213
- Thukral J, Moudgil P, Moudgil N, et. al. "Circulating Tumor DNA and Blood-Based Biomarkers for Predicting Cardiotoxicity in Cancer Therapy: Toward Precision Cardio-Oncology." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001205
- Sami N, Parikh MA, Mihatov N, et. al. "The Alpha-Gal Syndrome and Hypersensitivity to Biomaterials: Understanding Xenoimmunity." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001200
- Kallash M, Frishman WH. "Subcutaneous Furosemide, a Novel Therapy With Potential to Reduce Heart Failure Burden." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001208
